US cash merger arb
See what changed on your merger arb deals, and what's due.
One page for each deal you hold. See every change, every deadline and what's still pending. We check every day.
First 20 members get the launch price · One email when we open · No spam
Acme Biotherapeutics
ACMB- Deal type
- Cash merger, shareholder vote
- Buyer
- Globex Partners · private equity
- Offer
- $14.25 cash a share
- Value
- $640M
- Announced
- Jul 14, 2026
The deal so far
Globex Partners agreed on Jul 14 to buy Acme Biotherapeutics for $14.25 a share in cash, about $640M in all.
Announced: Jul 14. HSR waiting period ends: Aug 19. Go-shop ends: Sep 17. Record date to vote: Oct 2.
Globex Partners agreed on Jul 14 to buy Acme Biotherapeutics for $14.25 a share in cash, about $640M in all.
Globex Partners agreed on Jul 14 to buy Acme Biotherapeutics for $14.25 a share in cash, about $640M in all.
Announced: Jul 14. HSR waiting period ends: Aug 19. Go-shop ends: Sep 17. Record date to vote: Oct 2.
What's new since Sep 20
- Sep 24New to you:
Close date questioned
Expected close:
Fourth quarter of 2026, per the proxychanged to Early 2027, per a news reportWeb, news report · Sep 24
Sources disagree· both shown, not resolved
- Sep 22New to you:
Vote date set
Special meeting:
Not scheduledchanged to Nov 6, 2026
What to do, and by when
Oct 2
in 5 days
Hold shares to vote
Record date to vote. Hold shares at the close of business on this date to vote.
Official deadline
Price, delayed · Close Sep 25
$13.62
Offer $14.25 cash · −$0.06 on the week
- Spread
- 4.6%
- $0.63 a share
- Annualized
- 17.8%
- To Q4 2026
- Implied chance
- 88.4%
- Calculation
- Days to close
- 95
- Q4 2026
- Undisturbed (Jul 13)
- $10.10
- Up : down
- +$0.63 : −$3.52
- 3-month T-bills
- 4.05%
- vs T-bills
- +13.7 pts
- Implied, before bills
- 84.8%
- Avg daily volume
- 410k sh · $5.6M
- Market cap
- $560M
Implied chance is a calculation from market prices and the T-bill rate, not our view.
- Undisturbed (Jul 13)
- $10.10
- Up : down
- +$0.63 : −$3.52
- 3-month T-bills
- 4.05%
- vs T-bills
- +13.7 pts
- Implied, before bills
- 84.8%
- Avg daily volume
- 410k sh · $5.6M
- Market cap
- $560M
Implied chance is a calculation from market prices and the T-bill rate, not our view.
- Every factQuoted from the filing, with a link
- Every dayWe check filings and the web
“Any news?” shouldn't take an evening.
- The spread
The spread moves, and you can't tell if anything was filed.
- Checking
You check the company site, EDGAR, forums and your broker. One deal at a time.
- Deadlines
Miss a tender deadline or an election, and it costs you money.
- Conditions
A second request or a vote result changes what's left before closing, and only a filing says so.
- The slip
That works until one detail slips.
- Memory
With several deals, it all lives in a spreadsheet or in your head.
What you get
Every deal you hold, up to date. See every published change.
Browse every live deal for free. Then follow the ones you hold: every fact with its source, an email when something changes, and the deal maths on your own numbers.
Browse every live deal
Filter every live US cash merger by spread, size, buyer, stage and close date. Free.
Get an email when something changes
A term, a date or a condition changes? You get an email. Quiet week? You get a short summary.
and a daily web search of
- Press releases
- Regulators
- Court dockets
- News
See each deal's full story
What changed and when, on one page. Every fact shows the line from the filing.
Compare outcomes using your own numbers
Enter your own chance of closing, closing date and price. See the deal maths for each outcome: what you collect, what is at risk and the return a year.
- Every fact links to its sourceOne click opens the filing or page it came from.
- If sources disagree, you see bothWe never pick one for you.
- Accuracy creditA fact on your deal is wrong? You get a free month.
How it works
We read the filings and the web every day.
- 01
We read every new filing.
Merger agreements, proxies, tender offers and 8‑Ks. The whole document, not just the headline.
- 02
We search the web.
Press releases, regulators, court dockets and news. Each finding shows where it came from.
- 03
One page per deal.
New facts update the page. Old ones stay in the history.
- 04
Every quote is checked.
Every fact shows with its source and a quote that matches it word for word.
What Tracking Alpha does, and doesn't
What it does
- Follows the deals you hold
- Shows what changed
- Lists what you need to do, and when
- Reads the filings and searches the web every day
- Checks every quote against the filing
What it doesn't
- Send trade ideas
- Try to beat funds to the news
- Rate deals or guess if they'll close
- Give investment advice
From the builder
I'm a software engineer and a private investor. I tracked every deal by hand: reading filings, copying terms into spreadsheets, checking dates and looking for news. So I built a tool to do it for me.
- First: US cash merger arb
- Then more deal types
- Built in public, with your feedback
Jera Value@jera_value (opens in a new tab)
Pricing
Launch price.
First 20 members
$20
a month
Or $200 a year
30-day refund · Accuracy credit · Cancel anytime
Launch price for the first 20 members. Later members pay $29 a month or $290 a year. Members keep their price while they stay subscribed.
Included
- One page per deal, with sources
- What changed since you last looked
- What to do and when, with a reminder before each deadline
- What's still pending, and every key date
- Filings and a daily web search
- Every fact quoted from its source
- Your scenarios and expected return
- An email when something changes, and a weekly summary
Roadmap
US merger arb first. More to come.
At launch
US cash merger arb
- Cash mergers, small caps included
- Cash tender offers
- Deals that fail, kept on record
Next
Stock and mixed deals
- Exchange ratios and collars
- Cash or stock elections
Then, you vote
One type at a time
- Odd-lot tender offers
- Spin-offs
- Or something else you ask for
Not planned
Rumors and strategic reviews
They're not in the filings, so we'd be guessing.
Questions
Before you join.
Facts and sources, never advice. You decide.
Is this investment advice?
No. We show what the filings say and what changed. We never tell you what to buy, sell or hold.
Is it real-time?
No. We check every day. Prices are delayed.
Do I need to connect my broker?
No. Just pick your deals from the list. Shares and average cost are optional.
Which deals are covered?
US cash mergers and cash tender offers. Stock and mixed deals come next.
When does it open?
Soon. Join the waitlist and we'll email you once when it opens.
What will you do with my email?
One email when we open. That's it.
Join the waitlist
Stop checking EDGAR one deal at a time.
First 20 members get the launch price · One email when we open · No spam
Facts and sources, never advice. You make every decision.
